{"count": 4, "results": [{"_id": "38337129", "pmid": 38337129, "title": "Oral intake of bucillamine, carvedilol, metformin, or phenformin does not protect against UVR-induced squamous cell carcinomas in hairless mice.", "journal": "Photochem Photobiol Sci", "authors": ["Pihl C", "Bjerring P", "Andersen F", "Haedersdal M", "Lerche CM"], "date": "2024-02-09T00:00:00Z", "doi": "10.1007/s43630-024-00535-4", "meta_date_publication": "2024 Feb 9", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50242.727, "text_hl": "No change in @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumour@@@ development was observed in the four repurposed drug groups compared to the UV control group, whereas @CHEMICAL_Niacinamide @CHEMICAL_MESH:D009536 @@@nicotinamide@@@ significantly reduced @DISEASE_Carcinogenesis @DISEASE_MESH:D063646 @@@carcinogenesis@@@ (P = 0.00012). @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment significantly reduced UVR-induced @<m>DISEASE_Erythema</m> @DISEASE_MESH:D004890 @@@erythema@@@ (P = 0.012), @CHEMICAL_bucillamine @CHEMICAL_MESH:C026535 @@@bucillamine@@@ and @CHEMICAL_Phenformin @CHEMICAL_MESH:D010629 @@@phenformin@@@ increased dorsal @DISEASE_Pigmentation_Disorders @DISEASE_MESH:D010859 @@@pigmentation@@@ (P = 0.0013, and P = 0.0005), but no other photoprotective effect was observed across the repurposed groups. ", "citations": {"NLM": "Pihl C, Bjerring P, Andersen F, Haedersdal M, Lerche CM. Oral intake of bucillamine, carvedilol, metformin, or phenformin does not protect against UVR-induced squamous cell carcinomas in hairless mice. Photochem Photobiol Sci. 2024 Feb 9;():. PMID: 38337129", "BibTeX": "@article{38337129, title={Oral intake of bucillamine, carvedilol, metformin, or phenformin does not protect against UVR-induced squamous cell carcinomas in hairless mice.}, author={Pihl C and Bjerring P and Andersen F and Haedersdal M and Lerche CM}, journal={Photochem Photobiol Sci}}"}}, {"_id": "34786218", "pmid": 34786218, "pmcid": "PMC8577818", "title": "Fixed Drug Eruption Secondary to Four Anti-diabetic Medications: An Unusual Case of Polysensitivity", "journal": "Cureus", "authors": ["Al Masri D", "Fleifel M", "Hirbli K"], "date": "2021-10-08T00:00:00Z", "doi": "10.7759/cureus.18599", "meta_date_publication": "2021 Oct", "meta_volume": "13", "meta_issue": "10", "meta_pages": "e18599", "score": 50241.37, "text_hl": "It was accompanied by the appearance of @DISEASE_Blister @DISEASE_MESH:D001768 @@@blisters@@@, ulcerations, and @<m>DISEASE_Erythema</m> @DISEASE_MESH:D004890 @@@erythema@@@ (Figure 1). This was two weeks after the initiation of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Al Masri D, Fleifel M, Hirbli K. Fixed Drug Eruption Secondary to Four Anti-diabetic Medications: An Unusual Case of Polysensitivity Cureus. 2021 Oct;13(10):e18599. PMID: 34786218", "BibTeX": "@article{34786218, title={Fixed Drug Eruption Secondary to Four Anti-diabetic Medications: An Unusual Case of Polysensitivity}, author={Al Masri D and Fleifel M and Hirbli K}, journal={Cureus}, volume={13}, number={10}, pages={e18599}}"}}, {"_id": "28670544", "pmid": 28670544, "pmcid": "PMC5477448", "title": "Randomized Placebo Control Study of Metformin in Psoriasis Patients with Metabolic Syndrome (Systemic Treatment Cohort)", "journal": "Indian J Endocrinol Metab", "authors": ["Singh S", "Bhansali A"], "date": "2017-07-01T00:00:00Z", "doi": "10.4103/ijem.IJEM_46_17", "meta_date_publication": "2017 Jul-Aug", "meta_volume": "21", "meta_issue": "4", "meta_pages": "581-587", "score": 50042.883, "text_hl": "Intergroup comparisons for mean percentage change in PASI, ESI, and PGA scores at 12 weeks from baseline carried out by Student's t test. *@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ versus placebo, PASI: @DISEASE_Psoriasis @DISEASE_MESH:D011565 @@@Psoriasis@@@ area severity index, ESI: @<m>DISEASE_Erythema</m> @DISEASE_MESH:D004890 @@@Erythema@@@, scaling, and induration, PGA: Physician global assessment", "citations": {"NLM": "Singh S, Bhansali A. Randomized Placebo Control Study of Metformin in Psoriasis Patients with Metabolic Syndrome (Systemic Treatment Cohort) Indian J Endocrinol Metab. 2017 Jul-Aug;21(4):581-587. PMID: 28670544", "BibTeX": "@article{28670544, title={Randomized Placebo Control Study of Metformin in Psoriasis Patients with Metabolic Syndrome (Systemic Treatment Cohort)}, author={Singh S and Bhansali A}, journal={Indian J Endocrinol Metab}, volume={21}, number={4}, pages={581-587}}"}}, {"_id": "27531132", "pmid": 27531132, "pmcid": "PMC4987981", "title": "Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort)", "journal": "BMC Dermatol", "authors": ["Singh S", "Bhansali A"], "date": "2016-08-17T00:00:00Z", "doi": "10.1186/s12895-016-0049-y", "meta_date_publication": "2016 Aug 17", "meta_volume": "16", "meta_issue": "1", "meta_pages": "12", "score": 50042.21, "text_hl": "Statistically significant improvement was observed in @DISEASE_Psoriasis @DISEASE_MESH:D011565 @@@Psoriasis@@@ Area and Severity Index (PASI), @<m>DISEASE_Erythema</m> @DISEASE_MESH:D004890 @@@Erythema@@@, Scaling and Induration (ESI) and Physician global assessment (PGA) scores in @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@ (p values - PASI = 0.001, ESI = 0.002, PGA = 0.008) and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ groups (p values - PASI = 0.001, ESI = 0.016, PGA = 0.012) as compared to placebo. ", "citations": {"NLM": "Singh S, Bhansali A. Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort) BMC Dermatol. 2016 Aug 17;16(1):12. PMID: 27531132", "BibTeX": "@article{27531132, title={Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort)}, author={Singh S and Bhansali A}, journal={BMC Dermatol}, volume={16}, number={1}, pages={12}}"}}]}